Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa — Stella

Home/Dystrophic Epidermolysis Bullosa/

View on ClinicalTrials.gov

Recruiting

Back to Dystrophic Epidermolysis Bullosa trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Iran

Alzahra Hospital, Isfahan

Key details

Phase

Early testing / Safety & dosing

Sponsor

Isfahan University of Medical Sciences

Enrollment target

~20 participants

Started

January 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

3 Years – 35 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.